Alle Bell- en Gongceremonies

17252124ed1e300-512f-4b2d-aae1-993559bea487

BioFish admitted to trading

BioFish admitted to trading on Euronext Growth Oslo 3 August 2021.

BioFish admitted to trading 03/08/2021 - 8:43AM CEST Oslo

1725154a237142c-0bea-4d8b-bb32-e07663f5fd9f

Havila Kystruten admitted to trading

Havila Kystruten admitted to trading on Euronext Growth Oslo 3 August 2021.

Havila Kystruten admitted to trading 29/07/2021 - 8:50AM CEST Oslo

1725080befa9cfd-36ca-4bdb-939a-f000eb873e32

Draper Esprit lists on Euronext Dublin

Nicola McClafferty, Partner,  Edel Coen, Head of Dealflow and Philip O'Reilly, Head of Deal Execution, at Draper Esprit  closes the trading day in Dublin.

Draper Esprit plc is a venture capital investment company specializing in acquiring stakes in companies in recovery phase. At the end of March 2020, the portfolio amounted, in market value, to GBP 657.3 million.

 

Draper Esprit 23/07/2021 - 17:45PM CEST Dublin

17250622f2e08c6-bcc7-467b-984b-2613a17b012f

I2PO lists on Euronext Paris

Iris Knobloch, Founder, Chairwoman and CEO of I2PO opens the trading day in Paris.

Euronext congratulates I2PO, a Special Purpose Acquisition Company (SPAC) dedicated to the entertainment and leisure sector, on its listing on the professional compartment of Euronext’s regulated market in Paris (ticker code: I2PO).

I2PO, the first European SPAC dedicated to the entertainment and leisure sector was launched by entrepreneurs Iris Knobloch, along with Artemis, a patrimonial holding from the Pinault family represented by François-Henri Pinault and Alban Gréget, and Combat Holding, chaired by Matthieu Pigasse, the entity co-founded the 2MX Organic and Mediawan SPACs. I2PO has raised €275 million with the aim of acquiring one or several companies in the sub-sectors such as streaming and content distribution, music, intellectual property of media and services, electronic games and sports, online learning, and leisure platforms.

I2PO 20/07/2021 - 14:45PM CEST Paris

1725055600b1b25-8df5-4e9b-8273-ed8c5fc9951f

Kompuestos lists on Euronext Growth Paris

Ignacio Duch, Chairman and Chief Executive Officer of Kompuestos, opens the trading day in Paris.

Kompuestos S.A. is a manufacturing company specialized in designing and producing biodegradable resins and compounds for the plastic industry. Such compounds contain mineral fillers, colors and additive concentrates which provide plastics with the mechanical properties required as well as reducing their CO2 footprint. Kompuestos S.A. has developed proprietary knowhow and technology in the areas of the circular economy of plastics, including biodegradable and compostable resins, as well as knowhow for the recycling and reutilization processes for plastics. Kompuestos S.A. operates with two manufacturing facilities located in Barcelona.

Kompuestos 19/07/2021 - 16:25PM CEST Paris

1725051569e4f40-f8d7-4b68-94b5-3fa57c5c22f0

Biotalys lists on Euronext Brussels

Patrice Sellès, Chief Executive Officer of Biotalys, opens the trading day in Brussels.

Biotalys N.V. specializes in the development of products for crop and food protection. The company offers advanced protein-based biocontrols that effectively and selectively target pests and pathogens, while maintaining the protection of the environment.

Biotalys 19/07/2021 - 12:03PM CEST Brussels

172504617c111a5-5230-479b-9100-793b79e29f0e

Ikonisys lists on Euronext Growth Paris

Mario Crovetto, Chief Executive Officer of Ikonisys, opens the trading day in Paris.

Ikonisys S.A. is specialized in the design, manufacture and marketing of medical diagnostic equipment. The company offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing.

Ikonisys 19/07/2021 - 9:15AM CEST Paris

1725036bb8a27a7-2205-47de-bb9e-bb2cc469475c

Enogia lists on Euronext Growth Paris

Arthur Leroux, CEO of Enogia, and Antonin Pauchet, Deputy CEO of Enogia, open the trading day in Paris.

Enogia is specialized in the design, manufacture and marketing of heat-to-power conversion systems and air compressors for fuel cell integrators.

Enogia 14/07/2021 - 11:12AM CEST Paris

17250333e0523d1-a85d-469e-9097-2ea5177c482d

Blue Finance Challenge – UK-finale winnaars

Apricus heeft de UK-finale van de Blue Finance Challenge gewonnen. Lottie Newell, Managing Director van Apricus, luidde naar aanleiding hiervan virtueel de gong. Dit deed zij samen met mede studiegenoten van Tiffin Girl’s School. Apricus streeft ernaar om kleding sustainable en milieuvriendelijk te maken. Zij werden verwelkomd door Hanne Michiels, HR Officer van Euronext Amsterdam en Ambassadeur van de Blue Finance Challenge. De Blue Finance Challenge is een internationale samenwerking tussen JA Europe en Euronext N.V. voor jonge Blue Economy (‘Blauwe Economie’) ondernemers.

 

Blue Finance Challenge 14/07/2021 - 10:07AM CEST Amsterdam

1725032f79c4c4a-34a9-4372-bda3-267adac22d3f

Akobo Minerals admitted to trading

Akobo Minerals admitted to trading on Euronext Growth Oslo 14 July 2021.

Akobo Minerals admitted to trading 14/07/2021 - 8:42AM CEST Oslo

17250277cbfda2f-6793-448f-a617-e108a552fa4d

E-PANGO lists on Euronext Growth Paris

Philippe Girard, Chief Executive Officer of E-PANGO, opens the trading day in Paris.

E-PANGO specializes in the development of low-cost electricity production and distribution solutions for industrial and service enterprises, local authorities and multi-family housing management bodies.

E-PANGO 12/07/2021 - 15:40PM CEST Paris

1725022a9101644-b4c4-4b78-ba26-53ce9e0fe3ca

Vow Green Metals admitted to trading

Vow Green Metals admitted to trading on Euronext Growth Oslo 12 July 2021.

Vow Green Metals admitted to trading 12/07/2021 - 8:44AM CEST Oslo

172501797628d70-f061-4114-b293-af0c0ad57a33

Mercell lists on Oslo Børs

Mercell lists on Oslo Børs 9 July 2021.

Mercell lists on Oslo Børs 09/07/2021 - 8:47AM CEST Oslo

1725016e7733ab0-0b1c-4191-8127-dedc775c1e8b

Salmon Evolution lists on Oslo Børs

Salmon Evolution lists on Oslo Børs 9 July 2021.

Salmon Evolution lists on Oslo Børs 09/07/2021 - 8:37AM CEST Oslo

1725010d8cac47d-efd2-4609-9f41-6b155dc2b35a

Spartoo lists on Euronext Growth Paris

Boris Saragaglia, co-Founder, Chairman and Chief Executive Officer of Spartoo, opens the trading day in Paris.

Spartoo specializes in the online distribution of shoes, clothing and leather goods for women, men and children.

Operating in over 25 countries, including France, Germany, England, Italy and Spain, the company offers more than 3,500 brands and 300,000 models, and serves a traffic of more than 14 million unique visitors per month in Europe.

Spartoo lists on Euronext Growth Paris 07/07/2021 - 10:10AM CEST Paris

1724858d5a63199-cf38-470b-b0d8-d4019cf92225

BOA Concept lists on Euronext Growth Paris

Jean-Lucien Rascle, Chairman and co-Founder, and Chantal Ledoux, Chief Executive Officer and co-Founder of BOA Concept, open the trading day in Paris.

BOA Concept specializes in the manufacture and marketing of smart modular conveyors for warehouses. The modular conveyors, measuring between 1 and 3 m, are equipped with an electronic card that allows them to exchange information and facilitate product transfer, handling and shipping processes.

BOA Concept 06/07/2021 - 11:24AM CEST Paris

17248483c1c0f4b-1368-4605-ace9-d0ace8d26851

New Amsterdam Invest – SPAC-notering en eerste handelsdag

Aren van Dam, Sponsor & Managing Director van New Amsterdam Invest, luidde vandaag de gong naar aanleiding van de notering van New Amsterdam Invest, een Special Purpose Acquisition (SPAC) met focus op vastgoed. Hij werd verwelkomd door Simone Huis in ’t Veld, CEO van Euronext Amsterdam.

 

New Amsterdam Invest 06/07/2021 - 9:13AM CEST Amsterdam

172484769268d4b-5495-48ee-a572-8012c31c1aa7

NFL Biosciences lists on Euronext Growth Paris

Ignacio Faus, Chief Executive Officer, and Bruno Lafont, co-Founder and Chief Operations Officer of NFL Biosciences, open the trading day in Paris.

NFL Biosciences specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents.

The company currently has one product in the clinical development phase (NFL-101).

NFL Biosciences 05/07/2021 - 18:25PM CEST Paris